Human metallothionein expression under normal and pathological conditions: Mechanisms of gene regulation based on in silico promoter analysis

Critical Reviews in Eukaryotic Gene Expression

Volumn 19, Issue 4, 2009, Pages 301-317

  Laukens, Debby ^a   Waeytens, Anouk ^a   De Bleser, Pieter ^a   Cuvelier, Claude ^a   De Vos, Martine ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Cell cycle; Crohn's disease; Inflammation; Menkes disease; Methylation; MTF1; Stress; Wilson's disease

Indexed keywords

METALLOTHIONEIN; METALLOTHIONEIN I; METALLOTHIONEIN II; METALLOTHIONEIN III;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CROHN DISEASE; DOWN REGULATION; GENE CONTROL; HUMAN; IMMUNOHISTOCHEMISTRY; MENKES SYNDROME; METHYLATION; MOLECULAR CLONING; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PHYLOGENY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PSEUDOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSCRIPTION REGULATION; WILSON DISEASE;

MURINAE; MUS;

ALZHEIMER DISEASE; ANIMALS; CROHN DISEASE; GENE EXPRESSION REGULATION; HEPATOLENTICULAR DEGENERATION; HUMANS; MENKES KINKY HAIR SYNDROME; METALLOTHIONEIN; MICE; NEOPLASMS; PHYLOGENY; PROMOTER REGIONS, GENETIC;

EID: 70349264585     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v19.i4.40     Document Type: Review

References (136)

1. Kagi JH, Valee BL. Metallothionein: a cadmium-and zinc-containing protein from equine renal cortex. J Biol Chem. 1960;235:3460-3465
2. Nielson KB, Winge DR. Independence of the domains of metallothionein in metal binding. J Biol Chem. 1985;260:8698-8701
3. Zangger K, Armitage IM. Dynamics of interdomain and intermolecular interactions in mammalian metal-lothioneins. J Inorg Biochem. 2002;88:135-143
4. Dameron CT, Harrison MD. Mechanisms for protection against copper toxicity. Am J Clin Nutr. 1998;67:1091S-7S.
5. Sakurai A, Hara S, Okano N, Kondo Y, Inoue J, Imura N. Regulatory role of metallothionein in NF-kappaB activation. FEBS Lett. 1999;455:55-58
6. Kim CH, Kim JH, Lee J, Ahn YS. Zinc-induced NF-kappaB inhibition can be modulated by changes in the intracellular metallothionein level. Toxicol Appl Pharmacol. 2003;190:189-196
7. Ostrakhovitch EA, Olsson PE, Jiang S, Cherian MG. Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett. 2006;580:1235-1238
8. Zeng J, Heuchel R, Schafner W, Kagi JH. Tionein (apometallothionein) can modulate DNA binding and transcription activation by zinc fnger containing factor Sp1. FEBS Lett. 1991;279:310-312
9. Chung RS, West AK. A role for extracellular metal-lothioneins in CNS injury and repair. Neuroscience. 2004;123:595-599
10. Falck FY Jr, Fine LJ, Smith RG, Garvey J, Schork A, England B, McClatchey KD, Linton J. Metallothionein and occupational exposure to cadmium. Br J Ind Med. 1983;40:305-313
11. Lynes MA, Zafuto K, Unfricht DW, Marusov G, Samson JS, Yin X. Te physiological roles of extracellular metallothionein. Exp Biol Med (Maywood). 2006;231:1548-1554
12. Youn J, Hwang SH, Ryoo ZY, Lynes MA, Paik DJ, Chung HS, Kim HY. Metallothionein suppresses collagen-induced arthritis via induction of TGF-beta and down-regulation of proinfammatory mediators. Clin Exp Immunol. 2002;129:232-239
13. Inoue K, Takano H, Yanagisawa R, Sakurai M, Ichinose T, Sadakane K, Hiyoshi K, Sato M, Shimada A, Inoue M, Yoshikawa T. Role of metallothionein in antigen-related airway infammation. Exp Biol Med (Maywood). 2005;230:75-81.
14. Takano H, Inoue K, Yanagisawa R, Sato M, Shimada A, Morita T, Sawada M, Nakamura K, Sanbongi C, Yoshikawa T. Protective role of metallothionein in acute lung injury induced by bacterial endotoxin. Torax. 2004;59:1057-1062 (Pubitemid 39573925)
15. Zangger K, Oz G, Haslinger E, Kunert O, Armitage IM. Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: potential role at infammatory sites. FASEB J. 2001;15:1303-1305
16. Yin X, Knecht DA, Lynes MA. Metallothionein mediates leukocyte chemotaxis. BMC Immunol. 2005;6:21.
17. Teocharis SE, Margeli AP, Klijanienko J T, Kouraklis GP. Metallothionein expression in human neoplasia. Histopathology. 2004;45:103-118
18. Abdel-Mageed A, Agrawal KC. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ter. 1997;4:199-207.
19. Lim D, Jocelyn KM, Yip GW, Bay BH. Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1-to S-phase involving ATM and cdc25A signaling in breast cancer cells. Cancer Lett. 2009;276(1):109-117
20. Binz PA, Kagi JHR. Metallothionein: molecular evolution and classifcation. In: Klaassen CD, editor. Metallothionein IV. Basel: Birkhäuser Verlag; 1999. p. 7-13.
21. Karin M, Eddy RL, Henry WM, Haley LL, Byers MG, Shows TB. Human metallothionein genes are clustered on chromosome 16. Proc Natl Acad Sci U S A. 1984;81:5494-5498
22. Martin J, Han C, Gordon LA, Terry A, Prabhakar S, She X, Xie G, Hellsten U, Chan YM, Altherr M, Couronne O, Aerts A, Bajorek E, Black S, Blumer H, Branscomb E, Brown NC, Bruno WJ, Buckingham JM, Callen DF, Campbell CS, Campbell ML, Campbell EW, Caoile C, Challacombe JF, Chasteen LA, Chertkov O, Chi HC, Christensen M, Clark LM, Cohn JD, Denys M, Detter JC, Dickson M, Dimitrijevic-Bussod M, Escobar J, Fawcett JJ, Flowers D, Fotopulos D, Glavina T, Gomez M, Gonzales E, Goodstein D, Goodwin LA, Grady DL, Grigoriev I, Groza M, Hammon N, Hawkins T, Haydu L, Hildebrand CE, Huang W, Israni S, Jett J, Jewett PB, Kadner K, Kimball H, Kobayashi A, Krawczyk MC, Leyba T, Longmire JL, Lopez F, Lou Y, Lowry S, Ludeman T, Manohar CF, Mark GA, McMurray KL, Meincke LJ, Morgan J, Moyzis RK, Mundt MO, Munk AC, Nandkeshwar RD, Pitluck S, Pollard M, Predki P, Parson-Quintana B, Ramirez L, Rash S, Retterer J, Ricke DO, Robinson DL, Rodriguez A, Salamov A, Saunders EH, Scott D, Shough T, Stallings RL, Stalvey M, Sutherland RD, Tapia R, Tesmer JG, Tayer N, Tompson LS, Tice H, Torney DC, Tran-Gyamf M, Tsai M, Ulanovsky LE, Ustaszewska A, Vo N, White PS, Williams AL, Wills PL, Wu JR, Wu K, Yang J, Dejong P, Bruce D, Doggett NA, Deaven L, Schmutz J, Grimwood J, Richardson P, Rokhsar DS, Eichler EE, Gilna P, Lucas SM, Myers RM, Rubin EM, Pennacchio LA. Te sequence and analysis of duplication-rich human chromosome 16. Nature. 2004;432:988-994 (Pubitemid 40052223)
23. Schmidt CJ, Jubier MF, Hamer DH. Structure and expression of two human metallothionein-I iso-form genes and a related pseudogene. J Biol Chem. 1985;260:7731-7737
24. Mocchegiani E, Costarelli L, Giacconi R, Cipriano C, Muti E, Malavolta M. Zinc-binding proteins (metal-lothionein and alpha-2 macroglobulin) and immunose-nescence. Exp Gerontol. 2006;41:1094-1107
25. Garrett SH, Sens MA, Todd JH, Somji S, Sens DA. Expression of MT-3 protein in the human kidney. Toxicol Lett. 1999;105:207-214
26. van den Oord JJ, De Ley M. Distribution of metallo-thionein in normal and pathological human skin. Arch Dermatol Res. 1994;286:62-68
27. Mitropoulos D, Kyroudi-Voulgari A, Teocharis S, Serafetinides E, Moraitis E, Zervas A, Kittas C. Prognostic signifcance of metallothionein expression in renal cell carcinoma. World J Surg Oncol. 2005;3:5.
28. Tomita T, Matsubara O. Immunocytochemical localization of metallothionein in human pancreatic islets. Pancreas. 2000;20:21-24
29. Fuller CE, Elmes ME, Jasani B. Age-related changes in metallothionein, copper, copper-associated protein, and lipofuscin in human liver: a histochemical and immu-nohistochemical study. J Pathol. 1990;161:167-172
30. Kuppens K, De Ley M. Serum-induced expression of metallothionein isoforms in K-562 cells. Biochem Biophys Res Commun. 2006;342:979-983
31. Laukens D, Peeters H, Waeytens A, Bogaert S, Vander Cruyssen B, Elewaut D, et al. Reduced metallothi-onein expression in colonic Crohn's disease: evidence for a new disease-modifying gene. Gastroenterology. 2008;134:A-457.
32. Anne Cook H, Williams D, Anne Tomas G. Crypt-restricted metallothionein immunopositivity in murine colon: validation of a model for studies of somatic stem cell mutation. J Pathol. 2000;191:306-312
33. Elmes ME, Clarkson JP, Jasani B. Te immunocyto-chemical demonstration of metallothionein in human liver and small intestine. Acta Pharmacol Toxicol (Copenh). 1986;59:510-513
34. Clarkson JP, Elmes ME, Jasani B, Webb M. Histological demonstration of immunoreactive zinc metallothi-onein in liver and ileum of rat and man. Histochem J. 1985;17:343-352
35. Ioachim E, Michael M, Katsanos C, Demou A, Tsianos EV. Te immunohistochemical expression of metal-lothionein in infammatory bowel disease. Correlation with HLA-DR antigen expression, lymphocyte sub-populations and proliferation-associated indices. Histol Histopathol. 2003;18:75-82.
36. Kruidenier L, Kuiper I, Van Duijn W, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Verspaget HW. Imbalanced secondary mucosal antioxidant response in infammatory bowel disease. J Pathol. 2003;201:17-27.
37. Bruwer M, Schmid KW, Metz KA, Krieglstein CF, Senninger N, Schurmann G. Increased expression of metallothionein in infammatory bowel disease. Infamm Res. 2001;50:289-293
38. Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, Wilborn TW, Elson CO. Regulation of gene expression in infammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Infamm Bowel Dis. 2004;10:1-14.
39. Mulder TP, Verspaget HW, Janssens AR, de Bruin PA, Pena AS, Lamers CB. Decrease in two intestinal copper/ zinc containing proteins with antioxidant function in infammatory bowel disease. Gut. 1991;32:1146-1150
40. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profles and novel susceptibility candidate genes. Hum Mol Genet. 2001;10:445-456
41. Sturniolo GC, Mestriner C, Lecis PE, D'Odorico A, Venturi C, Irato P, Cecchetto A, Tropea A, Longo G, D'Inca R. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol. 1998;33:644-649
42. Mathew CG, Lewis CM. Genetics of infammatory bowel disease: progress and prospects. Hum Mol Genet. 2004;13 Spec No 1:R161-8.
43. Eckburg PB, Relman DA. Te role of microbes in Crohn's disease. Clin Infect Dis. 2007;44:256-262
44. Lansdown AB. Metallothioneins: potential therapeutic aids for wound healing in the skin. Wound Repair Regen. 2002;10:130-132
45. Okamoto R, Watanabe M. Cellular and molecular mechanisms of the epithelial repair in IBD. Dig Dis Sci. 2005;50(Suppl 1):S34-8.
46. Oz HS, Chen T, de Villiers WJ, McClain CJ. Metallothionein overexpression does not protect against infammatory bowel disease in a murine colitis model. Med Sci Monit. 2005;11:BR69-73.
47. Tran CD, Ball JM, Sundar S, Coyle P, Howarth GS. Te role of zinc and metallothionein in the dextran sulfate sodium-induced colitis mouse model. Dig Dis Sci. 2007;52:2113-2121
48. Stefanidou M, Maravelias C, Dona A, Spiliopoulou C. Zinc: a multipurpose trace element. Arch Toxicol. 2006;80:1-9.
49. Szczurek EI, Bjornsson CS, Taylor CG. Dietary zinc defciency and repletion modulate metallothionein immunolocalization and concentration in small intestine and liver of rats. J Nutr. 2001;131:2132-2138
50. Tran CD, Butler RN, Howarth GS, Philcox JC, Rofe AM, Coyle P. Regional distribution and localization of zinc and metallothionein in the intestine of rats fed diets difering in zinc content. Scand J Gastroenterol. 1999;34:689-695
51. Mulder TP, van der Sluys Veer A, Verspaget HW, Grifoen G, Pena AS, Janssens AR, Lamers CB. Efect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with infammatory bowel disease. J Gastroenterol Hepatol. 1994;9:472-477
52. Aschner M, West AK. Te role of MT in neurological disorders. J Alzheimers Dis. 2005;8:139-45; discussion 209-215
53. Tsuji S, Kobayashi H, Uchida Y, Ihara Y, Miyatake T. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. EMBO J. 1992;11:4843-4850
54. Yu WH, Lukiw WJ, Bergeron C, Niznik HB, Fraser PE. Metallothionein III is reduced in Alzheimer's disease. Brain Res. 2001;894:37-45.
55. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-infammatory signaling. J Neurosci Res. 2002;70:462-473
56. Erickson JC, Sewell AK, Jensen LT, Winge DR, Palmiter RD. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res. 1994;649:297-304.
57. Adlard PA, West AK, Vickers JC. Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease. Neurobiol Dis. 1998;5:349-356
58. Chung RS, Adlard PA, Dittmann J, Vickers JC, Chuah MI, West AK. Neuron-glia communication: metal-lothionein expression is specifcally up-regulated by astrocytes in response to neuronal injury. J Neurochem. 2004;88:454-461
59. Zambenedetti P, Giordano R, Zatta P. Metallothioneins are highly expressed in astrocytes and microcapil-laries in Alzheimer's disease. J Chem Neuroanat. 1998;15:21-26
60. Duguid JR, Bohmont CW, Liu NG, Tourtellotte WW. Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc Natl Acad Sci U S A. 1989;86:7260-7264
61. Hidalgo J, Penkowa M, Espejo C, Martinez-Caceres EM, Carrasco J, Quintana A, Molinero A, Florit S, Giralt M, Ortega-Aznar A. Expression of metallothionein-I,-II, and-III in Alzheimer disease and animal models of neuroinfammation. Exp Biol Med (Maywood). 2006;231:1450-1458 (Pubitemid 44547836)
62. Penkowa M. Metallothioneins are multipurpose neu-roprotectants during brain pathology. FEBS Journal. 2006;273:1857-1870
63. Sillevis Smitt PA, Mulder T P, Verspaget HW, Blaauwgeers HG, Troost D, de Jong JM. Metallothionein in amyotrophic lateral sclerosis. Biol Signals. 1994; 3:193-197
64. Sillevis Smitt PA, van Beek H, Baars AJ, Troost D, Louwerse ES, Krops-Hermus AC, de Wolf FA, de Jong JM. Increased metallothionein in the liver and kidney of patients with amyotrophic lateral sclerosis. Arch Neurol. 1992;49:721-724
65. Sillevis Smitt PA, Blaauwgeers HG, Troost D, de Jong JM. Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci Lett. 1992;144:107-110
66. Blaauwgeers HG, Anwar Chand M, van den Berg FM, Vianney de Jong JM, Troost D. Expression of diferent metallothionein messenger ribonucleic acids in motor cortex, spinal cord and liver from patients with amyo-trophic lateral sclerosis. J Neurol Sci. 1996;142:39-44.
67. Gong YH, Elliott JL. Metallothionein expression is altered in a transgenic murine model of familial amyo-trophic lateral sclerosis. Exp Neurol. 2000;162:27-36.
68. Nagano S, Satoh M, Sumi H, Fujimura H, Tohyama C, Yanagihara T, Sakoda S. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur J Neurosci. 2001;13:1363-1370
69. Bankier A. Menkes disease. J Med Genet. 1995;32:213-215
70. Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet. 1993;3:7-13.
71. Chelly J, Tumer Z, Tonnesen T, Petterson A, Ishikawa-Brush Y, Tommerup N, Horn N, Monaco AP. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet. 1993;3:14-19
72. Mercer JF, Livingston J, Hall B, Paynter JA, Begy C, Chandrasekharappa S, Lockhart P, Grimes A, Bhave M, Siemieniak D, Glover TW. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat Genet. 1993;3:20-25
73. Kodama H, Murata Y. Molecular genetics and pathophysiology of Menkes disease. Pediatr Int. 1999;41:430-435
74. Hamer DH. Metallothionein gene regulation in Menkes' syndrome. Arch Dermatol. 1987;123:1384a-5a.
75. Schmidt CJ, Hamer DH, McBride OW. Chromosomal location of human metallothionein genes: implications for Menkes' disease. Science. 1984;224:1104-1106
76. Garnica AD, Chan WY, Rennert OM. Role of metal-lothioneins in copper transport in patients with Menkes syndrome. Ann Clin Lab Sci. 1978;8:302-309
77. Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: Zinc therapy now treatment of choice. Brain Dev. 2006;5:5.
78. Borghesi LA, Lynes MA. Stress proteins as agents of immunological change: some lessons from metallothi-onein. Cell Stress Chaperones. 1996;1:99-108.
79. Manuel Y, Tomas Y, Pellegrini O. Metallothionein and tissue damage. IARC Sci Publ. 1992:231-237
80. Mofatt P, Seguin C. Expression of the gene encoding metallothionein-3 in organs of the reproductive system. DNA Cell Biol. 1998;17:501-510
81. Tate DJ, Miceli MV, Newsome DA. Expression of met-allothionein isoforms in human chorioretinal complex. Curr Eye Res. 2002;24:12-25.
82. Irie Y, Mori F, Keung WM, Mizushima Y, Wakabayashi K. Expression of neuronal growth inhibitory factor (metallothionein-III) in the salivary gland. Physiol Res. 2004;53:719-723
83. Dutta R, Sens DA, Somji S, Sens MA, Garrett SH, Shukla D. Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells. Prostate. 2002;52:89-97.
84. Tsuji S, Kobayashi H, Uchida Y, Ihara Y, Miyatake T. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. EMBO J. 1992;11:4843-4850
85. Hoey JG, Garrett SH, Sens MA, Todd JH, Sens DA. Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures, and renal cell carcinoma. Toxicol Lett. 1997;92:149-160
86. Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowicz BP, Palmiter RD. Induction of a new metallothionein isoform (MT-IV) occurs during difer-entiation of stratifed squamous epithelia. Biochemistry. 1994;33:7250-7259
87. Liang L, Fu K, Lee DK, Sobieski RJ, Dalton T, Andrews GK. Activation of the complete mouse metallothionein
88. Schmidt CJ, Hamer DH. Cell specifcity and an efect of ras on human metallothionein gene expression. Proc Natl Acad Sci U S A. 1986;83:3346-3350
89. Varshney U, Jahroudi N, Foster R, Gedamu L. Structure, organization, and regulation of human metallothionein IF gene: diferential and cell-type-specifc expression in response to heavy metals and glucocorticoids. Mol Cell Biol. 1986;6:26-37.
90. Searle PF, Davison BL, Stuart GW, Wilkie TM, Norstedt G, Palmiter RD. Regulation, linkage, and sequence of mouse metallothionein I and II genes. Mol Cell Biol. 1984;4:1221-1230
91. De Bleser P, Vlieghe D, Van Roy F. A distance diference matrix approach to the identifcation of transcription factors that regulate diferential gene expression in higher eukaryotes. Genome Research. 2006
92. Gedamu L, Varshney U, Jahroudi N, Foster R, Shworak NW. Structure and expression of the human metallothi-onein genes. Experientia Suppl. 1987;52:361-372
93. Shworak NW, O'Connor T, Wong NC, Gedamu L. Distinct TATA motifs regulate diferential expression of human metallothionein I genes MT-IF and MT-IG. J Biol Chem. 1993;268:24460-24466
94. Yang YY, Robbins PD, Lazo JS. Diferential transactiva-tion of human metallothionein-IIa in cisplatin-resistant and-sensitive cells. Oncol Res. 1998;10:85-98.
95. Roy AL, Meisterernst M, Pognonec P, Roeder RG. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature. 1991;354:245-248
96. Ghoshal K, Jacob ST. Regulation of metallothionein gene expression. Prog Nucleic Acid Res Mol Biol. 2001;66:357-384
97. Heuchel R, Radtke F, Georgiev O, Stark G, Aguet M, Schafner W. Te transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J. 1994;13:2870-2875
98. Westin G, Schafner W. A zinc-responsive factor interacts with a metal-regulated enhancer element (MRE) of the mouse metallothionein-I gene. EMBO J. 1988;7:3763-3770
99. Brugnera E, Georgiev O, Radtke F, Heuchel R, Baker E, Sutherland GR, Schafner W. Cloning, chromosomal mapping and characterization of the human metal-regulatory transcription factor MTF-1. Nucleic Acids Res. 1994;22:3167-3173
100. Jacob C, Maret W, Vallee BL. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc Natl Acad Sci U S A. 1998;95:3489-3494
101. Li Y, Kimura T, Huyck RW, Laity JH, Andrews GK. Zinc-induced formation of a coactivator complex containing the zinc-sensing transcription factor MTF-1, p300/CBP, and Sp1. Mol Cell Biol. 2008;28:4275-4284
102. Adams TK, Saydam N, Steiner F, Schafner W, Freedman JH. Activation of gene expression by metal-responsive signal transduction pathways. Environ Health Perspect. 2002;110(Suppl 5):813-817
103. Beyersmann D, Hechtenberg S. Cadmium, gene regulation, and cellular signalling in mammalian cells. Toxicol Appl Pharmacol. 1997;144:247-261
104. Karin M, Herschman HR. Dexamethasone stimulation of metallothionein synthesis in HeLa cell cultures. Science. 1979;204:176-177
105. Jacob ST, Ghoshal K, Sheridan JF. Induction of metal-lothionein by stress and its molecular mechanisms. Gene Expr. 1999;7:301-310
106. Kelly EJ, Sandgren EP, Brinster RL, Palmiter RD. A pair of adjacent glucocorticoid response elements regulate expression of two mouse metallothionein genes. Proc Natl Acad Sci U S A. 1997;94:10045-10050
107. De SK, McMaster MT, Andrews GK. Endotoxin induction of murine metallothionein gene expression. J Biol Chem. 1990;265:15267-15274
108. Coto JA, Hadden EM, Sauro M, Zorn N, Hadden JW. Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C. Proc Natl Acad Sci U S A. 1992;89:7752-7756
109. Schroeder JJ, Cousins RJ. Interleukin 6 regulates met-allothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc Natl Acad Sci U S A. 1990;87:3137-3141
110. Kasutani K, Itoh N, Kanekiyo M, Muto N, Tanaka K. Requirement for cooperative interaction of interleu-kin-6 responsive element type 2 and glucocorticoid responsive element in the synergistic activation of mouse metallothionein-I gene by interleukin-6 and glucocorticoid. Toxicol Appl Pharmacol. 1998; 151:143-151
111. Inoue K, Takano H, Shimada A, Wada E, Yanagisawa R, Sakurai M, Satoh M, Yoshikawa T. Role of metal-lothionein in coagulatory disturbance and systemic infammation induced by lipopolysaccharide in mice. FASEB J. 2006;20:533-535
112. Kanekiyo M, Itoh N, Kawasaki A, Matsuyama A, Matsuda K, Nakanishi T, Tanaka K. Metallothionein modulates lipopolysaccharide-stimulated tumour necrosis factor expression in mouse peritoneal macrophages. Biochem J. 2002;361:363-369
113. Murphy BJ, Kimura T, Sato BG, Shi Y, Andrews GK. Metallothionein induction by hypoxia involves cooperative interactions between metal-responsive transcription factor-1 and hypoxia-inducible transcription factor-1alpha. Mol Cancer Res. 2008;6:483-490
114. Yamasaki M, Nomura T, Sato F, Mimata H. Metallo-thionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells. Oncol Rep. 2007;18:1145-1153
115. Dalton T, Palmiter RD, Andrews GK. Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements. Nucleic Acids Res. 1994;22:5016-5023
116. Nagel WW, Vallee BL. Cell cycle regulation of metal-lothionein in human colonic cancer cells. Proc Natl Acad Sci U S A. 1995;92:579-583
117. Studer R, Vogt CP, Cavigelli M, Hunziker PE, Kagi JH. Metallothionein accretion in human hepatic cells is linked to cellular proliferation. Biochem J. 1997;328:63-67
118. Haerslev T, Jacobsen GK, Horn N, Damsgaard E. Metallothionein expression in placental tissue in Menkes' disease. An immunohistochemical study. APMIS. 1995;103:568-573
119. Miyashita H, Sato Y. Metallothionein 1 is a downstream target of vascular endothelial zinc fnger 1 (VEZF1) in endothelial cells and participates in the regulation of angiogenesis. Endothelium. 2005;12:163-170
120. Helin K, Wu CL, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C, Harlow E. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 1993;7:1850-1861
121. Meplan C, Mann K, Hainaut P. Cadmium induces conformational modifcations of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. J Biol Chem. 1999;274:31663-31670
122. Mitchell PJ, Wang C, Tjian R. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell. 1987;50:847-861
123. Andrews GK, Adamson ED, Gedamu L. Te ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene. Dev Biol. 1984;103:294-303.
124. Andrews GK, Lee DK, Ravindra R, Lichtlen P, Sirito M, Sawadogo M, Schafner W. Te transcription factors MTF-1 and USF1 cooperate to regulate mouse metallothionein-I expression in response to the essential metal zinc in visceral endoderm cells during early development. EMBO J. 2001;20:1114-1122
125. Sheng G, dos Reis M, Stern CD. Churchill, a zinc fnger transcriptional activator, regulates the transition between gastrulation and neurulation. Cell. 2003;115:603-613
126. Kageyama R, Merlino GT, Pastan I. Nuclear factor ETF specifcally stimulates transcription from promoters without a TATA box. J Biol Chem. 1989;264:15508-15514
127. Yang DC, Elliott RL, Head JF. Gene targets of antisense therapies in breast cancer. Expert Opin Ter Targets. 2002;6:375-385
128. Majumder S, Ghoshal K, Gronostajski RM, Jacob ST. Downregulation of constitutive and heavy metal-induced metallothionein-I expression by nuclear factor I. Gene Expr. 2001;9:203-215
129. Datta PK, Jacob ST. Identifcation of a sequence within the mouse metallothionein-I gene promoter mediating its basal transcription and of a protein interacting with this element. Cell Mol Biol Res. 1993;39:439-449
130. Tang CM, Westling J, Seto E. trans repression of the human metallothionein IIA gene promoter by PZ120, a novel 120-kilodalton zinc fnger protein. Mol Cell Biol. 1999;19:680-689
131. Nishimoto F, Sakata M, Minekawa R, Okamoto Y, Miyake A, Isobe A, Yamamoto T, Takeda T, Ishida E, Sawada K, Morishige K, Kimura T. Metal transcription factor-1 is involved in hypoxia-dependent regulation of placenta growth factor in trophoblast-derived cells. Endocrinology. 2009;150:1801-1808
132. Datta J, Majumder S, Kutay H, Motiwala T, Frankel W, Costa R, Cha HC, MacDougald OA, Jacob ST, Ghoshal K. Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/ enhancer binding protein alpha by phosphati-dylinositol 3-kinase signaling cascade. Cancer Res. 2007;67:2736-2746
133. Heguy A, West A, Richards RI, Karin M. Structure and tissue-specifc expression of the human metallothionein IB gene. Mol Cell Biol. 1986;6:2149-2157
134. Smith E, Drew PA, Tian ZQ, De Young NJ, Liu JF, Mayne GC, Ruszkiewicz AR, Watson DI, Jamieson GG. Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation. Mol Cancer. 2005;4:42.
135. Deng D, El-Rifai W, Ji J, Zhu B, Trampont P, Li J, Smith MF, Powel SM. Hypermethylation of metallothionein-3 CpG island in gastric carcinoma. Carcinogenesis. 2003;24:25-29
136. Majumder S, Kutay H, Datta J, Summers D, Jacob ST, Ghoshal K. Epigenetic regulation of metallothionein-i gene expression: diferential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins. J Cell Biochem. 2006;97:1300-1316